- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0714
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on ; volume:12 ; number:1 ; day:23 ; month:2 ; year:2017 ; pages:44-49 ; date:3.2017
Clinical research in cardiology supplements ; 12, Heft 1 (23.2.2017), 44-49, 3.2017
- Keyword
-
Kardiovaskuläre Krankheit
- Contributor
-
Schettler, V. J. J.
Neumann, C. L.
Peter, C.
Zimmermann, T.
Julius, U.
Roeseler, E.
Heigl, F.
Grützmacher, P.
Blume, H.
Vogt, A.
SpringerLink (Online service)
- DOI
-
10.1007/s11789-017-0089-9
- URN
-
urn:nbn:de:1111-201704054629
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schettler, V. J. J.
- Neumann, C. L.
- Peter, C.
- Zimmermann, T.
- Julius, U.
- Roeseler, E.
- Heigl, F.
- Grützmacher, P.
- Blume, H.
- Vogt, A.
- SpringerLink (Online service)
Other Objects (12)
Current Role of Lipoprotein Apheresis
The development of lipoprotein apheresis in Saxony in the last years
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Repeated lipoprotein apheresis and immune response : Effects on different immune cell populations
Aktuelle Situation der Lipoprotein-Apherese in Sachsen 2013 : = Actual situation of lipoprotein apheresis in Saxony in 2013
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy – successful treatment with lipoprotein apheresis
Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment
Current Role of Lipoprotein Apheresis
The development of lipoprotein apheresis in Saxony in the last years
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Repeated lipoprotein apheresis and immune response : Effects on different immune cell populations
Aktuelle Situation der Lipoprotein-Apherese in Sachsen 2013 : = Actual situation of lipoprotein apheresis in Saxony in 2013
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy – successful treatment with lipoprotein apheresis
Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment
Current Role of Lipoprotein Apheresis
The development of lipoprotein apheresis in Saxony in the last years
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Repeated lipoprotein apheresis and immune response : Effects on different immune cell populations
Aktuelle Situation der Lipoprotein-Apherese in Sachsen 2013 : = Actual situation of lipoprotein apheresis in Saxony in 2013
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy – successful treatment with lipoprotein apheresis